Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients

American Journal of Medical Genetics, Part A - Tập 132A Số 1 - Trang 49-53 - 2005
Kiarash Khosrotehrani1,2, Sylvie Bastuji‐Garin3, Vincent M. Riccardi4, Patricia Birch5, Jan M. Friedman5, P. Wolkenstein1
1Department of Dermatology and Réseau NF-Mondor, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil, France
2Department of Dermatology, Hôpital Tenon, AP-HP, Paris, France
3Department of Public Health, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil, France
4The Neurofibromatosis Institute, La Crescenta, California
5Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

Tóm tắt

AbstractNeurofibromatosis 1 (NF1) is a common genetic disorder with an autosomal dominant mode of inheritance, an increased morbidity and mortality, and a shorter lifespan. Although the disease is fully penetrant by the age of 8, the variability in symptoms and complications is high, even among members of the same family. The aim of this study was to identify easily recognizable clinical features that may be associated with mortality in a cohort of patients affected with NF1. We used prospectively collected data from the Neurofibromatosis Institute Database (NFID) and included in our analysis 703 patients who fulfilled the NIH diagnostic criteria for NF1. Clinical, especially dermatological features were tested as potential factors associated with mortality. Among the patients, 405 (57.6%) were children and 298 (42.4%) were adults. The mean follow‐up was 2.4 years (median = 0.98, range: 0–15.3 years). Forty patients died during follow‐up, mostly due to tumor development such as sarcoma (n = 18). In the adult population, subcutaneous neurofibromas (odds ratio [OR] = 3.6, 95% confidence interval (CI): [1.2–11.3], P = 0.02) and male gender (OR = 5.6, [1.5–20.9], P = 0.004) were independent predictors of mortality after adjustment for age. Among children, the presence of facial plexiform neurofibromas and pruritus were significantly associated with mortality in univariate analysis. Our study describes independent risk factors of mortality in a large cohort of adult and pediatric patients. Close follow‐up should be obtained for patients presenting with subcutaneous neurofibromas. © 2004 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1542/peds.105.3.608

10.1067/S0190-9622(03)01481-6

Easton DF, 1993, An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes, Am J Hum Genet, 53, 305

10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8

10.1001/jama.1997.03550010065042

10.1111/j.1346-8138.1995.tb03369.x

10.1001/archderm.139.2.187

10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W

Poyhonen M, 1997, Risk of malignancy and death in neurofibromatosis, Arch Pathol Lab Med, 121, 139

10.1086/320121

Riccardi VM, 1992, Neurofibromatosis: Phenotype, natural history, and pathogenesis

10.1056/NEJM198604173141603

10.1002/gepi.1129

10.1046/j.1365-2133.2000.03543.x

Zoller M, 1995, Life expectancy, mortality, and prognostic factors in neurofibromatosis type 1. A twelve‐year follow‐up of an epidemiological study in Goteborg, Sweden, Acta Derm Venereol, 75, 136, 10.2340/0001555575136140

10.1002/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N

Thông tin
Thông tin xuất bản

American Journal of Medical Genetics, Part A

Tập 132A Số 1

49-53

Thông tin tác giả